The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer’s disease
Journal of Alzheimers Disease 46(4):877–88, 2015
Glucagon-like peptide-1 receptor agonists increase pancreatic mass by induction of protein synthesis
Diabetes 64(3):1046–56, 2015
The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat
European Journal of Pharmacology 741:254-263, 2014
The sodium glucose cotransporter type 2 inhibitor empagliflozin preserves β-cell mass and restores glucose homeostasis in the male zucker diabetic fatty rat
The Journal of Pharmacology and Experimental Therapeutics 350(3):657–664, 2014
The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice
The Journal of Pharmacology and Experimental Therapeutics 350(2):353–360, 2014